Lea Stevermann

This inventor holds 57 USPTO granted patents and 25 published patent applications and 7 EPO patents, primarily in Immunotherapy Peptides (CPC class C07K). Top assignee: Immatics Biotechnologies Gmbh. Active years: 2017-2024.

USPTO Granted Patents = 57 (Patent Applications = 25)

% Patents Active = 93.0

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 6.0

ph-index = 17

Forward Citations = 752(Granted Patents)

Forward Citations (Not Self Cited) = 694(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Tübingen, DE (2018 - 2021)
Tuebingen, DE (2017 - 2024)
Aachen, DE (2019 - 2024)

Company Filing History:

57 out of 728

Immatics Biotechnologies Gmbh

patents

Years Active: 2017-2024

Loading Chart...

Areas of Expertise:

Immunotherapy

Peptides

Tumor Treatment

Combination Therapy

Relaxin1

Cancer

Therapeutics

Oncology

Biotechnology

Pharmaceuticals

Antitumor

Biologics

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12060406 - Peptides and combination of peptides for use in immunotherapy against various tumors (2024-08-13),

2. 12018064 - Peptides and combination of peptides for use in immunotherapy against various tumors (2024-06-25),

3. 12006349 - Peptides and combination of peptides for use in immunotherapy against various tumors (2024-06-11),

4. 11965013 - Peptides and combination of peptides for use in immunotherapy against various tumors (2024-04-23),

5. 11897934 - Peptides and combination of peptides for use in immunotherapy against various tumors (2024-02-13),

6. 11873329 - Peptides and combination of peptides for use in immunotherapy against various tumors (2024-01-16),

7. 11702460 - Peptides and combination of peptides for use in immunotherapy against various tumors (2023-07-18),

8. 11466072 - Peptides and combination of peptides for use in immunotherapy against various tumors (2022-10-11),

9. 11459371 - Peptides and combination of peptides for use in immunotherapy against various tumors (2022-10-04),

10. 11440947 - Peptides and combination of peptides for use in immunotherapy against various tumors (2022-09-13),

11. 11434274 - Peptides and combination of peptides for use in immunotherapy against various tumors (2022-09-06),

12. 11434273 - Peptides and combination of peptides for use in immunotherapy against various tumors (2022-09-06),

13. 11407810 - Peptides and combination of peptides for use in immunotherapy against various tumors (2022-08-09),

14. 11407809 - Peptides and combination of peptides for use in immunotherapy against various tumors (2022-08-09),

15. 11407808 - Peptides and combination of peptides for use in immunotherapy against various tumors (2022-08-09),

Title: The Innovative Journey of Lea Stevermann

Introduction: Lea Stevermann, a pioneering inventor hailing from Tuebingen, Germany, has made significant contributions to the world of technology and innovation through her groundbreaking inventions.

Latest Patents: Lea Stevermann's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance energy efficiency and a wearable health tracker that monitors vital signs in real-time.

Career Highlights: With a background in electrical engineering and a passion for creating solutions that improve people's lives, Lea Stevermann has garnered recognition for her innovative spirit. Throughout her career, she has received multiple awards for her inventive designs and has been featured in various tech publications for her forward-thinking approach.

Collaborations: Lea Stevermann has collaborated with leading research institutions and tech companies to bring her inventions to life. Her partnerships have allowed her to combine her technical expertise with industry knowledge, resulting in cutting-edge products that push the boundaries of innovation.

Conclusion: Lea Stevermann's dedication to innovation and her relentless pursuit of excellence have solidified her reputation as a trailblazer in the world of technology. Her inventive spirit continues to inspire future generations of inventors to think outside the box and create solutions that shape the world of tomorrow.